
About this episode
The Central government, a few days ago, banned 156 fixed dose combination drugs, or FDCs. An FDC is a drug that has more than one active ingredient – two or more drugs together, in a single pill, capsule or shot. This is the latest in a series of bans brought in by the Centre – last year 14 FDCs were banned, and a total of 499 have been banned since 2014.
Why is this happening? Expert committees of the government have said these FDCs are irrational or have no therapeutic value for patients. In fact, FDCs are known to contribute to a growing public health problem in India – antimicrobial resistance So then why is the Indian market dominated by FDCs? Why are there FDCs in India that are not found anywhere else in the world? How are even unapproved and banned FDCs often found in the market?
Guest: S Srinivasan, co-convenor, All India Drug Action Network
Host: Zubeda Hamid
Edited by Jude Francis Weston
Learn more about your ad choices. Visit megaphone.fm/adchoices
Get every episode summarized
Each time In Focus by The Hindu publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from In Focus by The Hindu

US-Iran war: Why did the Islamabad peace talks fail?
In Focus by The Hindu
Apr 14, 202642:45failed

Why are Central banks not raising interest rates despite rising oil prices?
In Focus by The Hindu
Apr 13, 202626:14failed

Tamil Nadu Assembly Elections: Can DMK retain power amid BJP’s push, AIADMK’s ch...
In Focus by The Hindu
Apr 10, 202627:53failed

Can Cuba weather its worst crisis in decades?
In Focus by The Hindu
Apr 9, 202638:33failed